White blood cell count and the occurrence of silent ischemia after myocardial infarction
Małgorzata Kurpesa1, Ewa Trzos, Maria Krzemińska-Pakuła
1Department of Cardiology, Institute of Medicine, Medical University of Łódź, Poland. kurpesa@ptkardio.pl
Insights
Asymptomatic patients post-myocardial infarction with elevated white blood cell (WBC) counts show a higher likelihood of residual ischemia. This finding highlights WBC count as a key indicator for silent ischemia after heart attack.
Area of Science:
- Cardiology
- Inflammation research
- Diagnostic markers
Background:
- Inflammation is implicated in atherosclerosis development.
- Inflammatory markers are explored as prognostic factors in coronary artery disease and acute coronary syndromes.
- The relationship between inflammation and silent postinfarction ischemia remains unclear.
Purpose of the Study:
- To investigate the correlation between white blood cell (WBC) count, an indicator of inflammation, and the presence of silent ischemia in asymptomatic patients after Q-wave myocardial infarction.
- To determine if elevated WBC count is an independent predictor of residual ischemia.
Main Methods:
- 104 asymptomatic patients with recent Q-wave myocardial infarction were enrolled.
- Patients were stratified into two groups based on white blood cell (WBC) count (< or = 7.0 x 103/microl and > 7.0 x 103/microl).
- Twenty-four-hour Holter monitoring was used to detect silent ischemic episodes.
Main Results:
- Silent ischemia was detected in 84% of patients with elevated WBC count versus 9% in the lower WBC count group (P < 0.01).
- A significant positive correlation was observed between WBC count and the number, amplitude, duration, and total burden of ischemic episodes.
- Multivariate analysis identified leucocytosis (elevated WBC count) as the sole independent predictor of silent ischemia.
Conclusions:
- Postinfarction patients who are asymptomatic but have an increased white blood cell (WBC) count are at higher risk for residual ischemia.
- Elevated WBC count serves as a significant indicator for the presence of silent ischemia in the post-myocardial infarction period.
Background:
Inflammation plays a role in the pathogenesis of atherosclerosis. Attempts are made to use markers of inflammation as prognostic factors in coronary artery disease and acute coronary syndromes. The correlation between inflammation and silent postinfarction ischemia is unknown.
Methods:
The study population consists of 104 asymptomatic patients who had uncomplicated Q-wave myocardial infarction within 6 months prior to the enrollment. After the white blood cell (WBC) count was assessed, the population was divided into two groups: group I comprising 48 patients with WBC < or = 7.0 x 103/microl and group II comprising 56 patients with WBC > 7.0 x 103/microl. Twenty-four-hour Holter monitoring was performed to detect the presence of silent ischemia.
Results:
Eighty-eight silent ischemic episodes were recorded. Ischemia on Holter monitoring was detected in 47 patients (84%) from group II and in five patients (9%) in group I (P < 0.01). We have found a significant positive correlation between WBC count and the number of ischemic episodes (r = 0.25), their maximal amplitude (r = 0.39), duration (r = 0.34), and total ischemic burden (r = 0.36). In multivariate analysis leucocytosis proved to be the only parameter independently correlated with the presence of silent ischemia.
Conclusion:
Postinfarction asymptomatic patients with increased WBC count are more likely to have residual ischemia.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction
Acute Coronary Syndrome I: Introduction
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

